Fumarate hydratase-IN-1
CAS No. 1644060-37-6
Fumarate hydratase-IN-1( —— )
Catalog No. M32930 CAS No. 1644060-37-6
Fumarate hydratase-IN-1 is a cell-permeable fumarate hydratase inhibitor with antiproliferative activity and can be used to study cellular activity.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 65 | In Stock |
|
| 2MG | 29 | In Stock |
|
| 5MG | 57 | In Stock |
|
| 10MG | 93 | In Stock |
|
| 25MG | 182 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameFumarate hydratase-IN-1
-
NoteResearch use only, not for human use.
-
Brief DescriptionFumarate hydratase-IN-1 is a cell-permeable fumarate hydratase inhibitor with antiproliferative activity and can be used to study cellular activity.
-
DescriptionFumarate hydratase-IN-1 (compound 2) is a cell-permeable fumarate hydratase inhibitor. Fumarate hydratase-IN-1 has antiproliferative activity against several cancer cell lines with a mean IC50 of 2.2 μM.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorMitochondrial Metabolism
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1644060-37-6
-
Formula Weight446.54
-
Molecular FormulaC27H30N2O4
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 50 mg/mL (111.97 mM; Ultrasonic )
-
SMILESCCOC(=O)[C@@]12CCCC=C1N(Cc1ccc(cc1)-c1ccccc1)C(=O)[C@H]2CC(=O)NC
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Takeuchi T et al. Identification of Fumarate Hydratase Inhibitors with Nutrient-Dependent Cytotoxicity. J Am Chem Soc, 2015 Jan 21, 137(2): 564-567.?
molnova catalog
related products
-
RK9, p17 Gag (20 - 2...
RK9, p17 Gag (20 - 28)
-
2E-3-formaldehydylos...
The herbs of Murraya exotica L.
-
Oxindole
Oxindole is an aromatic heterocyclic building block.?2-indolinone derivatives have become lead compounds in the research of kinase inhibitors.Oxindole structure has been used in receptor tyrosine kinases (RTKs) inhibitors such as SU4984 and intedanib, the RTK family represents an important therapeutic target for anti-cancer drug development.
Cart
sales@molnova.com